OpGen subsidiary Ares Genetics announces granting of key patent in China

January 26, 2023

https://www.globenewswire.com/news-release/2023/01/26/2595940/35690/en/OpGen-subsidiary-Ares-Genetics-announces-granting-of-key-patent-in-China.html

ROCKVILLE, Md., Jan. 26, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq:OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, and OpGen subsidiary, Ares Genetics (Ares), which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), announced today the granting of a key patent by the China National Intellectual Property Administration (CNIPA).

Read more at globenewswire.com

Related news for (OPGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.